1. Effect of lorcaserin on glycemic parameters in patients with type 2 diabetes mellitus. Issue 5 (27th March 2017) Authors: Magkos, Faidon; Nikonova, Elena; Fain, Randi; Zhou, Sharon; Ma, Tony; Shanahan, William Journal: Obesity Issue: Volume 25:Issue 5(2017) Page Start: 842 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy and safety of ralinepag, a novel oral IP agonist, in PAH patients on mono or dual background therapy: results from a phase 2 randomised, parallel group, placebo-controlled trial. Issue 4 (10th October 2019) Authors: Torres, Fernando; Farber, Harrison; Ristic, Arsen; McLaughlin, Vallerie; Adams, John; Zhang, Jinkun; Klassen, Preston; Shanahan, William; Grundy, John; Hoffmann, Ines; Cabell, Christopher; Escribano Subías, Pilar; Sood, Namita; Keogh, Anne; D'Souza, Gwyn; Rubin, Lewis Journal: European respiratory journal Issue: Volume 54:Issue 4(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Evaluation of lorcaserin on progression of prediabetes to type 2 diabetes and reversion to euglycemia. Issue 4 (18th May 2016) Authors: Nesto, Richard; Fain, Randi; Li, Yuhan; Shanahan, William Journal: Postgraduate medicine Issue: Volume 128:Issue 4(2016) Page Start: 364 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. GAVE bled, gave steroids, GAVE eradicated. Issue 6 (June 2022) Authors: Shanahan, William; Elguzouli, Khalid; Iqbal, Masood Journal: Digestive and liver disease Issue: Volume 54:Issue 6(2022) Page Start: 840 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Impact of lorcaserin on glycemic control in overweight and obese patients with type 2 diabetes: analysis of week 52 responders and nonresponders. Issue 6 (17th August 2016) Authors: Pi-Sunyer, Xavier; Shanahan, William; Fain, Randi; Ma, Tony; Garvey, W. Timothy Journal: Postgraduate medicine Issue: Volume 128:Issue 6(2016) Page Start: 591 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Lorcaserin treatment allows for decreased number needed to treat for weight and glycemic parameters in week 12 responders with ≥5% weight loss. Issue 8 (16th November 2016) Authors: Handelsman, Yehuda; Fain, Randi; Wang, Zhixiao; Li, Xuan; Fujioka, Ken; Shanahan, William Journal: Postgraduate medicine Issue: Volume 128:Issue 8(2016) Page Start: 740 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-179 Safety, Pharmacokinetics and Pharmacodynamics of Etrasimod (APD334), an Oral Selective S1P Receptor Modulator, After Dose-Escalation, in Healthy Volunteers. (February 2017) Authors: Peyrin-Biroulet, Laurent; Morgan, Michael; Christopher, Ronald; Raether, Brian; Lassen, Cheryl; Sanchez-Kam, Matilde; Shanahan, William Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P-180 Etrasimod (APD334), a Potent, Selective, Oral S1P Receptor Modulator with Autoimmune Disease-Modifying Activity Exhibiting Favorable PK/PD Properties in Healthy Volunteers. (February 2017) Authors: Schreiber, Stefan; Morgan, Michael; Christopher, Ronald; Raether, Brian; Lassen, Cheryl; Sanchez-Kam, Matilde; Shanahan, William; Panes, Julian Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. P-250 Preclinical Safety Assessment of Etrasimod (APD334), an Oral Sphingosine-1-phosphate Receptor (S1P) Modulator with a Unique Profile. (February 2017) Authors: Christopher, Ronald; Gatlin, Joe; Ennis, Bruce; Whelan, Kevin; Morgan, Michael; Yoon, Woo Hyun; Tang, Yong; Al-Shamma, Hussien; Unett, David; Shanahan, William Journal: Inflammatory bowel diseases Issue: Volume 23(2017)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Rat liver ECM incorporated into electrospun polycaprolactone scaffolds as a platform for hepatocyte culture. Issue 12 (23rd June 2022) Authors: Bate, Thomas S. R.; Shanahan, William; Casillo, Joseph P.; Grant, Rhiannon; Forbes, Stuart J.; Callanan, Anthony Journal: Journal of biomedical materials research Issue: Volume 110:Issue 12(2022) Page Start: 2612 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗